We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.88%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.05B
AUM Growth
+$375M
Cap. Flow
+$361M
Cap. Flow %
34.49%
Top 10 Hldgs %
24.89%
Holding
5,677
New
1,360
Increased
1,920
Reduced
1,136
Closed
1,108

Sector Composition

Rank Sector Weight
1 Financials 6.05%
2 Technology 5.64%
3 Industrials 5.17%
4 Consumer Discretionary 4.28%
5 Healthcare 3.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
R icon
3276
Ryder
R
$10.1B
$6K ﹤0.01%
+92
New +$6.09K
RPV icon
3277
Invesco S&P 500 Pure Value ETF
RPV
$1.68B
$6K ﹤0.01%
109
-39,024
-100% -$1.99M
RUSHB icon
3278
Rush Enterprises Class B
RUSHB
$6.14B
$6K ﹤0.01%
673
+169
+34% +$1.46K
SABA
3279
Saba Capital Income & Opportunities Fund II
SABA
$223M
$6K ﹤0.01%
+453
New +$5.83K
SAH icon
3280
Sonic Automotive
SAH
$2.61B
$6K ﹤0.01%
344
-696
-67% -$12K
SBR
3281
Sabine Royalty Trust
SBR
$1.05B
$6K ﹤0.01%
+175
New +$5.78K
SKYW icon
3282
Skywest
SKYW
$4.34B
$6K ﹤0.01%
197
-652
-77% -$14.9K
SQM icon
3283
Sociedad Química y Minera de Chile
SQM
$20.6B
$6K ﹤0.01%
258
-1,854
-88% -$40.7K
TLF icon
3284
Tandy Leather Factory
TLF
$20M
$6K ﹤0.01%
856
-295
-26% -$2.1K
TOK icon
3285
iShares MSCI Kokusai Fund
TOK
$257M
$6K ﹤0.01%
125
-424
-77% -$22.2K
TPST icon
3286
Tempest Therapeutics
TPST
$14.6M
-1
Closed -$22.8K
TSBK icon
3287
Timberland Bancorp
TSBK
$351M
$6K ﹤0.01%
429
+274
+177% +$3.9K
USPH icon
3288
US Physical Therapy
USPH
$1.22B
$6K ﹤0.01%
100
-545
-84% -$29.9K
VCLT icon
3289
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.85B
$6K ﹤0.01%
+64
New +$5.83K
VIGI icon
3290
Vanguard International Dividend Appreciation ETF
VIGI
$9.3B
$6K ﹤0.01%
100
+95
+1,900% +$5.18K
WMS icon
3291
Advanced Drainage Systems
WMS
$10.9B
$6K ﹤0.01%
+217
New +$5.28K
WTBA icon
3292
West Bancorporation
WTBA
$485M
$6K ﹤0.01%
322
+222
+222% +$4.09K
XENE icon
3293
Xenon Pharmaceuticals
XENE
$6.12B
$6K ﹤0.01%
886
-1,458
-62% -$10K
TBNK
3294
DELISTED
Territorial Bancorp Inc.
TBNK
$6K ﹤0.01%
+216
New +$5.61K
CUTR
3295
DELISTED
Cutera, Inc.
CUTR
$6K ﹤0.01%
589
+88
+18% +$965
SIEN
3296
DELISTED
Sientra, Inc.
SIEN
$6K ﹤0.01%
92
-303
-77% -$20.9K
USDP
3297
DELISTED
USD PARTNERS LP
USDP
$6K ﹤0.01%
+605
New +$5.91K
CFMS
3298
DELISTED
Conformis, Inc. Common Stock
CFMS
$6K ﹤0.01%
+36
New +$8.46K
HLG
3299
DELISTED
Hailiang Education Group Inc. American Depositary Shares
HLG
$6K ﹤0.01%
670
+100
+18% +$840
NSEC
3300
DELISTED
National Security Group Inc
NSEC
$6K ﹤0.01%
343
+337
+5,617% +$5.5K

Similar funds

Tower Research Capital (TRC)'s Q2 2016 Portfolio in Review

As of Q2 2016, Tower Research Capital (TRC) held 5,677 positions worth $1.05B, up 56% from $672M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $361M of net new capital in Q2 2016, opening 1,360 new positions and adding to 1,920 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.

By sector, the portfolio is most concentrated in Financials at 6.1% of assets, up from 2.5% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $48M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2016 buy was iShares Russell 1000 Growth ETF: 247,708 shares worth $6.21M.
  • Tower Research Capital (TRC) added most to State Street SPDR Dow Jones Industrial Average ETF Trust in Q2 2016, an estimated $24.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2016 reduction was iShares Russell 2000 ETF, cutting an estimated $48M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2016, selling an estimated $9.09M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.05B portfolio in Q2 2016.
  • Tower Research Capital (TRC) opened 1,360 new positions and closed 1,108 in Q2 2016.
  • Tower Research Capital (TRC)'s portfolio value rose 56% quarter-over-quarter to $1.05B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.